Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects With Partly Controlled Atopic Asthma [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the safety, tolerability, and pharmacokinetics of ADC3680B in partly controlled atopic asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ADC3680B

Snippet

Sponsor: Pulmagen Therapeutics | Conditions: Atopic Asthma | Phase 2 | Status: COMPLETED